186 related articles for article (PubMed ID: 17384080)
1. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
Gaggar A; Li Y; Weathington N; Winkler M; Kong M; Jackson P; Blalock JE; Clancy JP
Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L96-L104. PubMed ID: 17384080
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.
Jackson PL; Xu X; Wilson L; Weathington NM; Clancy JP; Blalock JE; Gaggar A
Mol Med; 2010; 16(5-6):159-66. PubMed ID: 20111696
[TBL] [Abstract][Full Text] [Related]
3. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
4. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Garratt LW; Sutanto EN; Ling KM; Looi K; Iosifidis T; Martinovich KM; Shaw NC; Kicic-Starcevich E; Knight DA; Ranganathan S; Stick SM; Kicic A;
Eur Respir J; 2015 Aug; 46(2):384-94. PubMed ID: 25929954
[TBL] [Abstract][Full Text] [Related]
6. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis.
Delacourt C; Le Bourgeois M; D'Ortho MP; Doit C; Scheinmann P; Navarro J; Harf A; Hartmann DJ; Lafuma C
Am J Respir Crit Care Med; 1995 Aug; 152(2):765-74. PubMed ID: 7633740
[TBL] [Abstract][Full Text] [Related]
7. An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis.
Devereux G; Steele S; Jagelman T; Fielding S; Muirhead R; Brady J; Grierson C; Brooker R; Winter J; Fardon T; McCormick J; Huang JT; Miller D
J Cyst Fibros; 2014 Sep; 13(5):557-63. PubMed ID: 24525080
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha.
Ratjen F; Hartog CM; Paul K; Wermelt J; Braun J
Thorax; 2002 Nov; 57(11):930-4. PubMed ID: 12403873
[TBL] [Abstract][Full Text] [Related]
9. Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation.
Kong MY; Li Y; Oster R; Gaggar A; Clancy JP
PLoS One; 2011; 6(8):e22596. PubMed ID: 21857935
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.
Fischer N; Hentschel J; Markert UR; Keller PM; Pletz MW; Mainz JG
Pediatr Pulmonol; 2014 Nov; 49(11):1065-75. PubMed ID: 24464968
[TBL] [Abstract][Full Text] [Related]
11. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
12. Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis.
Hajj R; Lesimple P; Nawrocki-Raby B; Birembaut P; Puchelle E; Coraux C
J Pathol; 2007 Feb; 211(3):340-50. PubMed ID: 17186573
[TBL] [Abstract][Full Text] [Related]
13. Exhaled breath condensate MMP-9 levels in children with bronchiectasis.
Karakoc GB; Inal A; Yilmaz M; Altintas DU; Kendirli SG
Pediatr Pulmonol; 2009 Oct; 44(10):1010-6. PubMed ID: 19725099
[TBL] [Abstract][Full Text] [Related]
14. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.
Turnbull AR; Pyle CJ; Patel DF; Jackson PL; Hilliard TN; Regamey N; Tan HL; Brown S; Thursfield R; Short C; Mc Fie M; Alton EWFW; Gaggar A; Blalock JE; Lloyd CM; Bush A; Davies JC; Snelgrove RJ
J Cyst Fibros; 2020 Jan; 19(1):40-48. PubMed ID: 31176670
[TBL] [Abstract][Full Text] [Related]
15. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase activity in pediatric acute lung injury.
Kong MY; Gaggar A; Li Y; Winkler M; Blalock JE; Clancy JP
Int J Med Sci; 2009; 6(1):9-17. PubMed ID: 19159011
[TBL] [Abstract][Full Text] [Related]
17. sTREM-1 is elevated in cystic fibrosis and correlates with proteases.
Forrester DL; Barr HL; Fogarty A; Knox A
Pediatr Pulmonol; 2017 Apr; 52(4):467-471. PubMed ID: 28068000
[TBL] [Abstract][Full Text] [Related]
18. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.
Kong MY; Clancy JP; Peng N; Li Y; Szul TJ; Xu X; Oster R; Sullender W; Ambalavanan N; Blalock JE; Gaggar A
Eur Respir J; 2014 Apr; 43(4):1086-96. PubMed ID: 24311764
[TBL] [Abstract][Full Text] [Related]
20. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.
Gaggar A; Jackson PL; Noerager BD; O'Reilly PJ; McQuaid DB; Rowe SM; Clancy JP; Blalock JE
J Immunol; 2008 Apr; 180(8):5662-9. PubMed ID: 18390751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
